38TERA Trademark
Serial Number: 79321465 • Registration: 6886599
38TERA is a trademark filed by
Tera Labs Pty Ltd
on August 25, 2021. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
David D. Kalish Coats & Bennett, PLLC
1400 Crescent Green
Suite 300
Cary
NC 27518
Trademark Details
Filing Date
August 25, 2021
Registration Date
November 1, 2022
Published for Opposition
August 16, 2022
Filing History
UNDELIVERABLE MAIL - NO ACTION TAKEN
May 28, 2024 UNDN
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 21, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 23, 2023 FICS
FINAL DISPOSITION PROCESSED
Feb 23, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 1, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 1, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 1, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Aug 16, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 16, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 16, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 27, 2022 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 27, 2022 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 27, 2022 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 14, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 13, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 13, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 13, 2022 TROA
REFUSAL PROCESSED BY IB
Jul 12, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 22, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jun 22, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 2, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jun 1, 2022 CNRT
ASSIGNED TO EXAMINER
May 31, 2022 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Nov 19, 2021 NREP
APPLICATION FILING RECEIPT MAILED
Oct 12, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 7, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 30, 2021 REPR
